Who
Francisco Trust under agreement dated February 28, 1996
10% owner
Company insider
Files Form 4 as: 10% owner, Dyadic International.
In numbers
- Trades disclosed
- 32
- Buys
- 0
- Sells
- 14
- Bought
- $0
- Sold
- $118.2B
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 6 Feb 2006
- Last trade
- 24 Jul 2026
- Last filed
- 24 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 24 Jul 2026filed 24 Jul 2026 | DYAI Dyadic InternationalBiotechnology | SEC FORM 4 Sold | $3,1732,616 at $1.21 | filing |
| 24 Jul 2026filed 24 Jul 2026 | DYAI Dyadic InternationalBiotechnology | SEC FORM 4 Sold | $3,1652,616 at $1.21 | filing |
| 23 Jul 2026filed 24 Jul 2026 | DYAI Dyadic InternationalBiotechnology | SEC FORM 4 Sold | $71K54,760 at $1.30 | filing |
| 23 Jul 2026filed 24 Jul 2026 | DYAI Dyadic InternationalBiotechnology | SEC FORM 4 Sold | $71K54,760 at $1.30 | filing |
| 22 Jul 2026filed 24 Jul 2026 | DYAI Dyadic InternationalBiotechnology | SEC FORM 4 Sold | $50K38,016 at $1.33 | filing |
| 22 Jul 2026filed 24 Jul 2026 | DYAI Dyadic InternationalBiotechnology | SEC FORM 4 Sold | $51K38,016 at $1.33 | filing |
| 23 Dec 2025filed 6 Jul 2026 | DYAI Dyadic Internationaloption or derivative · Biotechnology | SEC FORM 4 Code J | —238,095 at $0.00 | filing |
| 23 Dec 2025filed 6 Jul 2026 | DYAI Dyadic Internationaloption or derivative · Biotechnology | SEC FORM 4 Code J | —238,095 at $0.00 | filing |
| 7 Jan 2025filed 6 Jul 2026 | DYAI Dyadic InternationalBiotechnology | SEC FORM 4 Sold | $30K15,000 at $2.01 | filing |
| 7 Jan 2025filed 6 Jul 2026 | DYAI Dyadic InternationalBiotechnology | SEC FORM 4 Sold | $30K15,000 at $2.01 | filing |
| 6 Jan 2025filed 6 Jul 2026 | DYAI Dyadic InternationalBiotechnology | SEC FORM 4 Sold | $38K20,000 at $1.92 | filing |
| 6 Jan 2025filed 6 Jul 2026 | DYAI Dyadic InternationalBiotechnology | SEC FORM 4 Sold | $38K20,000 at $1.92 | filing |
| 30 Dec 2024filed 6 Jul 2026 | DYAI Dyadic InternationalBiotechnology | SEC FORM 4 Sold | $79K40,000 at $1.98 | filing |
| 30 Dec 2024filed 6 Jul 2026 | DYAI Dyadic InternationalBiotechnology | SEC FORM 4 Sold | $79K40,000 at $1.98 | filing |
| 24 Dec 2024filed 6 Jul 2026 | DYAI Dyadic InternationalBiotechnology | SEC FORM 4 Sold | $9,1925,100 at $1.80 | filing |
| 24 Dec 2024filed 6 Jul 2026 | DYAI Dyadic InternationalBiotechnology | SEC FORM 4 Sold | $9,1805,100 at $1.80 | filing |
| 23 Dec 2024filed 6 Jul 2026 | DYAI Dyadic InternationalBiotechnology | SEC FORM 4 Sold | $76K41,143 at $1.84 | filing |
| 23 Dec 2024filed 6 Jul 2026 | DYAI Dyadic InternationalBiotechnology | SEC FORM 4 Sold | $76K41,143 at $1.84 | filing |
| 20 Dec 2024filed 6 Jul 2026 | DYAI Dyadic InternationalBiotechnology | SEC FORM 4 Sold | $47K25,281 at $1.87 | filing |
| 20 Dec 2024filed 6 Jul 2026 | DYAI Dyadic InternationalBiotechnology | SEC FORM 4 Sold | $47K25,281 at $1.87 | filing |
News
Lisata Therapeutics (NASDAQ:LSTA) versus Dyadic International (NASDAQ:DYAI) Head to Head ContrastDYAI · dailypolitical.com · 22 Oct 2026
0 headlines in the last 90 days name Francisco Trust under agreement dated February 28, 1996; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.